Log In
BCIQ
Print this Print this
 

Mitoxantrone HCL Liposome

  Manage Alerts
Collapse Summary General Information
Company CSPC Pharmaceutical Group Ltd.
DescriptionMitoxantrone hydrochloride liposome injection
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Fatty acid/lipid
Latest Stage of DevelopmentPhase II
Standard IndicationLymphoma
Indication DetailsTreat lymphoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today